Escames 2018 MiP2018: Difference between revisions

From Bioblast
No edit summary
No edit summary
Β 
Line 1: Line 1:
{{Abstract
{{Abstract
|title=[[Image:Germaine.jpg|left|90px|Germaine Escames]] Suppression of AKT/mTOR pathway and activation of mitophagy by melatonin via mitocondrial regulation in head and neck cancer.
|title=[[Image:Germaine.jpg|left|90px|Germaine Escames]] Suppression of AKT/mTOR pathway and activation of mitophagy by melatonin via mitocondrial regulation in head and neck cancer. [[Media:Germaine_Latvia.pdf|Escames_Presentation]]
|info=[[MiP2018]]
|info=[[MiP2018]]
|authors=Escames G, Guerra-Librero A, Fernandez-Gil BI, Florido J, Martinez-Ruiz L, Rodriguez-Santana C, Garcia-Checa J, Acuna-Castroviejo D
|authors=Escames G, Guerra-Librero A, Fernandez-Gil BI, Florido J, Martinez-Ruiz L, Rodriguez-Santana C, Garcia-Checa J, Acuna-Castroviejo D

Latest revision as of 10:33, 16 October 2018

Germaine Escames
Suppression of AKT/mTOR pathway and activation of mitophagy by melatonin via mitocondrial regulation in head and neck cancer. Escames_Presentation

Link: MiP2018

Escames G, Guerra-Librero A, Fernandez-Gil BI, Florido J, Martinez-Ruiz L, Rodriguez-Santana C, Garcia-Checa J, Acuna-Castroviejo D (2018)

Event: MiP2018

COST Action MitoEAGLE

At the request of the author, this abstract is not made available online.


β€’ Bioblast editor: Plangger M, Kandolf G β€’ O2k-Network Lab: ES Granada Acuna-Castroviejo D


Labels: MiParea: Respiration, Pharmacology;toxicology  Pathology: Cancer 

Organism: Human, Mouse  Tissue;cell: Other cell lines 



HRR: Oxygraph-2k 


Affiliations

Escames G(1,2), Guerra-Librero (A), Fernandez-Gil BI(1), Florido J(1), MartΓ­nez-Ruiz L, RodrΓ­guez-Santana C(1), GarcΓ­a-Checa J(1), AcuΓ±a-Castroviejo D(1,2)

  1. Centro InvestigaciΓ³n BiomΓ©dica, Parque TecnolΓ³gico de Ciencias de la Salud
  2. Fac Medicina; Univ Granada, Spain. - [email protected]

Support

Supported in part by grant nΒΊ SAF2009-14037 (Ministerio de Competitividad y Fondos Feder)

Cookies help us deliver our services. By using our services, you agree to our use of cookies.